Showing results (271-280 of 2,409) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|April 1, 2025
A Swedish cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in the treatment of iron deficiency anemia in patients with inflammatory bowel diseaseStefan C Lindgren, Hans Strid, Henrik Hjortswang, et al.Journal of Medical Economics|September 16, 2025
Assessment of unmet clinical needs and healthcare resource use among statin-treated patients with or at risk of developing atherosclerotic cardiovascular diseaseNancy Ortiz, Jacqueline Shehata, Jeremy Smart, et al.Journal of Medical Economics|September 19, 2025
Cost-effectiveness analysis of universal hypothyroidism screening in the general population aged 30-65 years in SpainCarles Zafón Llopis, Olga Vicente López, Mª Ángeles Cruz Martos, et al.Journal of Medical Economics|September 13, 2025
Budget impact analysis of skytrofa for the treatment of pediatric growth hormone deficiency in a US health planEmily Boller, Subhara Raveendran, Alden Smith, et al.Journal of Medical Economics|October 25, 2025
Economic evaluation of a bivalent respiratory syncytial virus prefusion F vaccine for older adults in Sweden: cost-effectiveness and budget impactMáté Szilcz, Parissa Naghipour, Ann-Charlotte Fridh, et al.Journal of Medical Economics|October 24, 2025
Nirmatrelvir/ritonavir treatment for COVID-19: an economic value systematic literature reviewTendai Mugwagwa, José Marcano Belisario, Louise Hartley, et al.Journal of Medical Economics|October 15, 2025
Cost-consequence analysis of three cardiac ablation technologies in paroxysmal atrial fibrillationPetr Neužil, Angel Ferrero de Loma-Osorio, Ángel Martínez Brotons, et al.Journal of Medical Economics|August 4, 2025
Safety and efficacy of an intrinsic antitachycardia pacing algorithm in patients from Japan and South Korea: results from a cardiac device registry in the Asia Pacific regionMasahiko Goya, Seung-Jung Park, Kenji Ando, et al.Journal of Medical Economics|September 17, 2013
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in treatment-experienced chronic hepatitis C genotype 1 patientsSandrine Cure, Florence Bianic, Sandra Gavart, et al.Journal of Medical Economics|September 6, 2013
Validation of an economic model of paliperidone palmitate for chronic schizophreniaThomas R Einarson, Michiel E H HemelsPageof 241